CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Executive Vice Chairman bought 1,538 shares at $2.94 ($4,522)
- 4 Open-market buy Director bought 2,190 shares at $2.96 ($6,482)
- 4 Open-market buy Chief Executive Officer bought 1,800 shares at $2.85 ($5,130)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $2.81 ($5,620)
- 10-Q Report Quarterly Report
- 8-K/A Event Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
Page 6 of 31 · 605 filings